Nan Li, Ph.D.
- Center for Cancer Research
- National Cancer Institute
Nan earned her Ph.D. in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham. Her current research focuses on the development of chimeric antigen receptor (CAR) T cells targeting glypicans (e.g., GPC2 and GPC3) for treating solid tumors. She has won the NCI Director’s Innovation Award in 2017 and 2021.
Areas of Expertise
1) immunotherapy 2) antibody engineering